Serum protein biomarkers for juvenile dermatomyositis: a pilot study.

Shefa M TawalbehWilfredo MarinGabrielle A MorganUtkarsh J DangYetrib HathoutLauren M Pachman

Published in: BMC rheumatology (2020)

Blood accessible protein biomarkers reflecting JDM pathophysiology were identified; some of them rebounded after therapy was tapered. Further studies bridging these biomarkers to specific clinical features of JDM are required to confirm the clinical utility of these serum protein biomarkers.

Keyphrases

protein protein
amino acid
binding protein
interstitial lung disease
systemic lupus erythematosus
mesenchymal stem cells
systemic sclerosis
bone marrow
disease activity
smoking cessation